In Vivo Analysis of T lymphocytes in the Persistently Infected CNS

持续感染中枢神经系统中 T 淋巴细胞的体内分析

基本信息

  • 批准号:
    8026029
  • 负责人:
  • 金额:
    $ 45.55万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-03-01 至 2013-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The central nervous system (CMS) poses a unique challenge to the immune system, as it is considered an immunologically specialized compartment that resides behind a non-fenestrated barrier and significantly limits the expression of antigen-presenting machinery. Because the CNS is compartmentalized and imposes strict regulatory mechanisms on the adaptive immune system, a multitude of pathogens that infect humans (e.g. HIV, herpes virus, measles virus, HTLV-1, JC virus, etc.) are capable of establishing persistence in the CNS. These persistent infections can give rise to severe behavioral alterations and neurological dysfunction, which adversely affects human health. Persistent infections that gain access to the CNS often do so by first establishing persistence in the periphery. This common scenario consequently presents biomedical researchers with the challenge of eradicating the pathogen from both the periphery as well as the CNS. Given that the CNS provides such a favorable environment to viruses seeking persistence, we postulate that achieving clearance from this specialized compartment will be far more challenging than from peripheral tissues. The proposed study will explore a murine model system in which an immunosuppressive virus is introduced through a peripheral route and then establishes prolonged persistence in the CNS despite the eventual clearance from the periphery. Clearance from the periphery coincides with a functional reactivation of virus-specific T cells (a scenario we hope to achieve in humans), yet this response is unable to prevent prolonged viral persistence within the CNS. Importantly, administration of exogenous memory T lymphocytes at the peak of CNS viral infection results in efficient clearance of the virus from both the periphery and the CNS. Thus, an adoptively transferred population of memory T lymphocytes can achieve successful clearance despite an inadequate endogenous immune response. The proposed study is designed to significantly advance our understanding of T cell immunity to persistent viral infections in the CNS by establishing the shortcomings of the endogenous T cell response (Specific Aim#1) and the modus operand of a highly successful adoptive response (Specific Aim#2). The main objective of this research is mechanistically define the factors that give rise to successful CNS viral clearance so that we are better able to supplement a failing (or inadequate) endogenous response.
描述(由申请人提供):中枢神经系统(CMS)对免疫系统提出了独特的挑战,因为它被认为是一个免疫特异性的隔室,位于无孔屏障后面,显著限制了抗原呈递机制的表达。由于中枢神经系统是区隔的,并对适应性免疫系统施加严格的调节机制,许多感染人类的病原体(如HIV、疱疹病毒、麻疹病毒、HTLV-1、JC病毒等)能够在中枢神经系统中建立持久性。这些持续感染可引起严重的行为改变和神经功能障碍,对人类健康产生不利影响。进入中枢神经系统的持续性感染通常首先在外周建立持久性。因此,这种常见的情况向生物医学研究人员提出了从外周和中枢神经系统根除病原体的挑战。鉴于中枢神经系统为寻求持久性的病毒提供了如此有利的环境,我们假设从这个专门的隔室获得清除将比从外周组织获得清除要困难得多。该研究将探索一个小鼠模型系统,其中免疫抑制病毒通过外周途径引入,然后在中枢神经系统中建立持久的持久性,尽管最终从外周清除。来自外周的清除与病毒特异性T细胞的功能性再激活相一致(我们希望在人类中实现这种情况),然而这种反应无法阻止病毒在中枢神经系统内的长时间持续存在。重要的是,在中枢神经系统病毒感染的高峰期,外源性记忆T淋巴细胞的管理导致病毒从外周和中枢神经系统的有效清除。因此,尽管内源性免疫反应不足,但过继性转移的记忆T淋巴细胞群体可以成功清除。本研究旨在通过确定内源性T细胞应答的缺陷(Specific Aim#1)和高度成功的过继应答的操作方式(Specific Aim#2),显著提高我们对中枢神经系统持续病毒感染的T细胞免疫的理解。本研究的主要目的是从机制上确定导致中枢神经系统病毒成功清除的因素,以便我们能够更好地补充失败(或不充分)的内源性反应。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MICHAEL B OLDSTONE其他文献

MICHAEL B OLDSTONE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MICHAEL B OLDSTONE', 18)}}的其他基金

Host Genetic Factors to Combat Lassa Hemorrhagic Fever
对抗拉沙出血热的宿主遗传因素
  • 批准号:
    8573827
  • 财政年份:
    2013
  • 资助金额:
    $ 45.55万
  • 项目类别:
Host Genetic Factors to Combat Lassa Hemorrhagic Fever
对抗拉沙出血热的宿主遗传因素
  • 批准号:
    8711266
  • 财政年份:
    2013
  • 资助金额:
    $ 45.55万
  • 项目类别:
Host Genetic Factors to Combat Lassa Hemorrhagic Fever
对抗拉沙出血热的宿主遗传因素
  • 批准号:
    9118852
  • 财政年份:
    2013
  • 资助金额:
    $ 45.55万
  • 项目类别:
Pathogenesis of Acute Respiratory Diseases: SARS and INFLUENZA
急性呼吸道疾病的发病机制:SARS 和流感
  • 批准号:
    8609326
  • 财政年份:
    2012
  • 资助金额:
    $ 45.55万
  • 项目类别:
Novel Chemical and Immunological Approaches to Influenza Therapy
流感治疗的新化学和免疫学方法
  • 批准号:
    7288013
  • 财政年份:
    2007
  • 资助金额:
    $ 45.55万
  • 项目类别:
Novel Chemical and Immunological Approaches to Influenza Therapy
流感治疗的新化学和免疫学方法
  • 批准号:
    8076285
  • 财政年份:
    2007
  • 资助金额:
    $ 45.55万
  • 项目类别:
Novel Chemical and Immunological Approaches to Influenza Therapy
流感治疗的新化学和免疫学方法
  • 批准号:
    7864328
  • 财政年份:
    2007
  • 资助金额:
    $ 45.55万
  • 项目类别:
In Vivo Analysis of T lymphocytes in the Persistently Infected CNS
持续感染中枢神经系统中 T 淋巴细胞的体内分析
  • 批准号:
    7570017
  • 财政年份:
    2007
  • 资助金额:
    $ 45.55万
  • 项目类别:
Novel Chemical and Immunological Approaches to Influenza Therapy
流感治疗的新化学和免疫学方法
  • 批准号:
    7626430
  • 财政年份:
    2007
  • 资助金额:
    $ 45.55万
  • 项目类别:
Novel Chemical and Immunological Approaches to Influenza Therapy
流感治疗的新化学和免疫学方法
  • 批准号:
    7433177
  • 财政年份:
    2007
  • 资助金额:
    $ 45.55万
  • 项目类别:

相似海外基金

cGAS-STING Pathway Targeting Replicative Adenoviruses with CD46 Tropism and AFP Promoter Conditional Replication Restriction for the Treatment of Hepatocellular Carcinoma
cGAS-STING 通路靶向具有 CD46 趋向性和 AFP 启动子的复制腺病毒条件性复制限制用于治疗肝细胞癌
  • 批准号:
    10436626
  • 财政年份:
    2021
  • 资助金额:
    $ 45.55万
  • 项目类别:
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
  • 批准号:
    10557162
  • 财政年份:
    2021
  • 资助金额:
    $ 45.55万
  • 项目类别:
Molecular therapy of replication-competent adenoviruses targeting characteristic gene mutations found in mesothelioma
针对间皮瘤中发现的特征基因突变的具有复制能力的腺病毒的分子疗法
  • 批准号:
    21K08199
  • 财政年份:
    2021
  • 资助金额:
    $ 45.55万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
  • 批准号:
    10330464
  • 财政年份:
    2021
  • 资助金额:
    $ 45.55万
  • 项目类别:
Structural characterization of nucleoprotein cores of human adenoviruses
人腺病毒核蛋白核心的结构表征
  • 批准号:
    9807741
  • 财政年份:
    2019
  • 资助金额:
    $ 45.55万
  • 项目类别:
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
  • 批准号:
    41625-2013
  • 财政年份:
    2018
  • 资助金额:
    $ 45.55万
  • 项目类别:
    Discovery Grants Program - Individual
The therapeutic strategies with augmented replications of oncolytic adenoviruses for malignant mesothelioma
溶瘤腺病毒增强复制治疗恶性间皮瘤的治疗策略
  • 批准号:
    18K15937
  • 财政年份:
    2018
  • 资助金额:
    $ 45.55万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
  • 批准号:
    41625-2013
  • 财政年份:
    2017
  • 资助金额:
    $ 45.55万
  • 项目类别:
    Discovery Grants Program - Individual
Exploring the effects of nutrient deprivation on T cells and oncolytic adenoviruses, in order to create immune activators for tumour therapy
探索营养剥夺对 T 细胞和溶瘤腺病毒的影响,以创造用于肿瘤治疗的免疫激活剂
  • 批准号:
    1813152
  • 财政年份:
    2016
  • 资助金额:
    $ 45.55万
  • 项目类别:
    Studentship
Research on detection of novel adenoviruses by genetic methods
新型腺病毒的基因检测研究
  • 批准号:
    16K09118
  • 财政年份:
    2016
  • 资助金额:
    $ 45.55万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了